Connection

Michael Joyner to Coronavirus Infections

Back to Details
This is a "connection" page, showing publications Michael Joyner has written about Coronavirus Infections.
Michael Joyner
Connection Strength
0.150
Coronavirus Infections
  1. In Reply-How Safe Is COVID-19 Convalescent Plasma? Mayo Clin Proc. 2021 08; 96(8):2281-2282.
    View in: PubMed
    Score: 0.030
  2. In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients. Mayo Clin Proc. 2020 12; 95(12):2802-2803.
    View in: PubMed
    Score: 0.028
  3. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J Clin Invest. 2020 09 01; 130(9):4791-4797.
    View in: PubMed
    Score: 0.028
  4. Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clin Proc. 2020 09; 95(9):1888-1897.
    View in: PubMed
    Score: 0.028
  5. Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy. Clin Infect Dis. 2021 08 02; 73(3):e540-e542.
    View in: PubMed
    Score: 0.008
  6. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. J Clin Invest. 2020 10 01; 130(10):5112-5114.
    View in: PubMed
    Score: 0.007
  7. Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors. Mayo Clin Proc. 2020 11; 95(11):2343-2349.
    View in: PubMed
    Score: 0.007
  8. A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals. JAMA. 2020 08 04; 324(5):455-457.
    View in: PubMed
    Score: 0.007
  9. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 06 01; 130(6):2757-2765.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.